Kevin Roche

On and on it goes, and so do the research summaries.

Another look at the week-over-week analysis shows uncertainty over direction of epidemic.

The epidemic winds own with a very low rate of actual case detection, but also a very low rate of any serious disease. Let's let it go.

The latest in the regular series showing the age distribution of all events during the epidemic.

Not sure what the wastewater analysis is telling us.

The final age group, everyone over age 65, where boosters show continuing benefit.

On to the middle aged group for our breakthrough event analysis.

On to the 118 to 49 age group, where there appears to be some remaining benefit of vax in preventing hospitalization.

The next age group for the detailed breakthrough analysis is the 12-17 year-olds.

Breaking the breakthru data into smaller age group posts.

Medicare covers about a fifth of all Americans and the hospital part of the program has an imminent financing crisis.

Summer blossoms as do our ongoing efforts to keep you up on the research.

During the Omicron wave vaccine performance, including boosters, has steadily trended down, and has basically zero effectiveness in the total population now.